17

Potential use of CpG ODN for cancer immunotherapy

Year:
2006
Language:
english
File:
PDF, 344 KB
english, 2006
18

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants

Year:
2001
Language:
english
File:
PDF, 112 KB
english, 2001
25

The role of CpG in DNA vaccines

Year:
2000
Language:
english
File:
PDF, 539 KB
english, 2000
26

CpG DNA is an effective oral adjuvant to protein antigens in mice

Year:
2000
Language:
english
File:
PDF, 218 KB
english, 2000
27

Current opportunities and challenges in intradermal vaccination

Year:
2015
Language:
english
File:
PDF, 808 KB
english, 2015
29

Optimization Strategies for DNA Vaccines

Year:
2000
Language:
english
File:
PDF, 282 KB
english, 2000
37

Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences

Year:
2016
Language:
english
File:
PDF, 1.51 MB
english, 2016
41

Novel Adjuvant Systems

Year:
2001
Language:
english
File:
PDF, 57 KB
english, 2001